Search Results 1441-1450 of 20015 for Hepatitis b

  1. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Have active hepatitis B or hepatitis C defined as: HBV: hepatitis B surface ... hepatitis B core antibody (HBc Ab) positive subjects;; HCV: HCV ...

  2. Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides - Mayo Clinic

    active Hepatitis B or Hepatitis C. Antiviral prophylaxis for chronic Hepatitis B virus infection may be used at the discretion of the investigator.

  3. Golimumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Hepatitis B, history of or; Immune system problem or; Primary sclerosing cholangitis (bile duct disease) or; Tuberculosis, history of or; Granulomatosis ...

  4. Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma - Mayo Clinic

    Has known history of chronic infection with hepatitis B virus (hepatitis B surface antigen positive) or hepatitis C virus (detectable anti-hepatitis C ...

  5. A Study to Assess the Safety and Preliminary Effectiveness of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    ... B-Cell Lymphoma (DLBCL). Print details. Share; Facebook · Twitter. Overview ... positive test results for active hepatitis B and C;; known seropositive for ...

  6. Amphotericin b lipid complex (intravenous route, injection route) - Side effects & dosage - Mayo Clinic

    Description. Amphotericin B lipid complex is an antifungal medicine. It is used to help the body overcome serious infections caused by fungus. This medicine is ...

  7. Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

    ... hepatitis B (hepatitis B surface antigen [HBsAg] and/or total hepatitis B core antibody [anti-HBc]) or HCV antibody. Unless required by local regulations ...

  8. Study of MK-8242 Alone and in Combination with Cytarabine in Participants with Acute Myelogenous Leukemia (P07649) - Mayo Clinic

    Arm B is for participants with recurrent AML ... B. Participation eligibility. Participant ... Clinically significant hepatitis at Screening, or hepatitis ...

  9. 6 Mayo Clinic researchers selected for Diversity in Clinical Trials Career Development Award

    ... hepatitis B- and C-induced hepatocellular carcinoma, a special at-risk population that is underrepresented in immunotherapy trials, yet could derive immense ...

  10. Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant - Mayo Clinic

    Known hepatitis B or hepatitis C infection; EXCEPTION: if viral load < 800,000 IU/L; Phase I: active dermatologic disease >= grade 3. Participating Mayo ...